Business · 09/01/2006

FDA Publishes Draft Guidance for Herpes Simplex Virus Serological Assays

The Food and Drug Administration (FDA) has released a draft guidance document outlining the requirements for serological assays to test for Herpes Simplex Virus Types 1 and 2, as part of a proposed rule to reclassify these devices from class III to class II devices.